Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study

被引：0
|
作者：
Plachta-Danielzik, S. [1 ]
Bokemeyer, B. [1 ,2 ,3 ]
Efken, P. [4 ]
Mohl, W. [5 ]
Hoffstadt, M. [6 ]
Krause, T. [7 ]
Schweitzer, A. [8 ]
Schnoy, E. [9 ]
Ehehalt, R. [10 ]
Trentmann, L. [11 ]
Teich, N. [12 ]
Atreya, R. [13 ]
Franzenburg, S. [1 ]
Hartmann, P.
Wenske, T. [1 ]
Schreiber, S. [1 ]
机构：
[1] Competence Network IBD, Study Dept, Kiel, Germany
[2] Interdisciplinary Crohn Colitis Ctr Minden, Crohn Colitis Ctr, Minden, Germany
[3] Univ Hosp Schleswig Holstein Campus Kiel, Clin Gen Internal Med 1, Kiel, Germany
[4] Gastroenterol Practice Minden, Minden, Germany
[5] Ctr Gastroenterol Saar MVZ, Saarbrucken, Germany
[6] Gastroenterol Practice Iserlohn, Iserlohn, Germany
[7] Gastroenterol Practice Kassel, Kassel, Germany
[8] Gastroenterol Practice Muenster, Munster, Germany
[9] Univ Hosp Augsburg, III Med Clin, Augsburg, Germany
[10] Gastroenterol Practice Heidelberg, Heidelberg, Germany
[11] Gastroenterol Practice Bremen, Bremen, Germany
[12] Gastroenterol Practice Leipzig, Leipzig, Germany
[13] Friedrich Alexander Univ Erlangen Nuernberg, Med Clin 1, Erlangen, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P784
引用
收藏
页码：918 / 919
页数：2
相关论文
共 50 条
  • [21] Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics
    Bokemeyer, B.
    Plachta-Danielzik, S.
    Sobotzki, C.
    Mohl, W.
    Hoffstadt, M.
    Krause, T.
    Atreya, R.
    Von der Ohe, M.
    Graefe, U.
    Trentmann, L.
    Eisold, M.
    Linde, A.
    Franzenburg, S.
    Moser, M.
    Hartmann, P.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S584 - S584
  • [22] Vedolizumab in IBD-Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
    Engel, Tal
    Ungar, Bella
    Yung, Diana E.
    Ben-Horin, Shomron
    Eliakim, Rami
    Kopylov, Uri
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (02): : 245 - 257
  • [23] Proportion of IBD patients with suboptimal control in daily clinical practice - real-world evidence from the IBD Podcast study
    Dignass, A.
    D'Amico, F.
    Gomollon, F.
    Bamias, G.
    Magro, F.
    Heatta-Speicher, T.
    Michelena, N.
    Leitner, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I786 - I787
  • [24] Real-world effectiveness of vedolizumab in managing refractory pouchitis: a multicenter study on intravenous to subcutaneous transition
    Gimeno-Pitarch, L.
    Minguez, A.
    Cespedes, E.
    Ferreiro-Iglesias, R.
    Martin-Arranz, M. D.
    Sicilia, B.
    Lorca, I
    Huguet, J. M.
    Mesonero, F.
    Vicente, R.
    Nos, P.
    Iborra, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1610 - I1611
  • [25] Real-World Effectiveness of Upadacitinib in Patients with Moderate/ Severe Rheumatoid Arthritis: 6-Month Data from the Observational UPHOLD Study
    Ostor, Andrew
    Feist, Eugen
    Sidiropoulos, Prodromos
    Avouac, Jerome
    Rebella, Martin
    Namas, Rajaie
    Frediani, Bruno
    Hsieh, Song-Chou
    Gao, Tianming
    Khan, Nasser
    Strengholt, Sander
    Lagunes-Galindo, Ivan
    Attar, Susan
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 821 - 824
  • [26] Darifenacin in a real-world practice: results of a 6-month phase IV. trial
    Hajdinjak, Tine
    Leskovar, Jurij
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2013, 82 (05): : 288 - 297
  • [27] REAL-WORLD TRENDS IN CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS INITIATING VEDOLIZUMAB OVER TIME IN ISRAEL
    Weil, C.
    Chodick, G.
    Shalev, V
    Demuth, D.
    Petrakis, I
    Ben Baruch, O.
    Tsukinovsky, S.
    Yarden, A.
    VALUE IN HEALTH, 2018, 21 : S142 - S142
  • [28] REAL-WORLD EXPERIENCE FOR BIOLOGIC USE IN IBD IN THAI: A SINGLECENTER EXPERIENCE
    Limsrivilai, Julajak
    Chaemsupaphan, Thanaboon
    Sattayalertyanyong, Onuma
    Subdee, Nichcha
    Permpim, Parinya
    Pausawasdi, Nonthalee
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S54 - S54
  • [29] Real-world use of the IBD disk tool in unselected cohorts of outpatients
    Sharma, N.
    Savelkoul, E.
    Disney, B.
    Shah, A.
    De Silva, S.
    Pattni, S.
    Iacucci, M.
    Cooney, R.
    Ghosh, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S196 - S197
  • [30] Real-world experience of subcutaneous infliximab use in children with inflammatory bowel disease (IBD) at a tertiary paediatric centre
    Eldredge, J.
    Kaur, R.
    Tano, M.
    Chidgey, T.
    Singh, N.
    Chuah, C. W.
    Magoffin, A.
    Thacker, K.
    O'Loughlin, E.
    Dutt, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1832 - i1833
12345